Share This Link

Ventricular fibrillation is a life-threatening arrhythmia with disorganized ventricular electrical activity causing no cardiac output. It requires immediate defibrillation, not synchronized cardioversion. Absence of a pulse and collapse defines its emergency management pathway.

First-degree heart block involves prolonged PR interval >0.20 seconds with intact conduction. It is usually asymptomatic and benign, requiring no acute intervention. Electrical cardioversion is not indicated because there is no hemodynamic compromise or unstable rhythm.

Sinus tachycardia is a physiologic response to stressors such as hypovolemia, fever, or pain. Management focuses on treating the underlying cause rather than rhythm correction. Cardioversion is inappropriate since the rhythm originates from a normal sinus node mechanism.

Administering a potassium-wasting diuretic promotes renal excretion of potassium, but its effect is not immediate. In chronic kidney disease, reduced renal function limits efficacy. It does not address urgent cardiac instability risk associated with elevated potassium levels.

Encouraging avoidance of potassium-rich foods is a long-term management strategy for chronic hyperkalemia. It does not provide rapid correction of dangerously elevated potassium levels. Immediate intervention must prioritize prevention of life-threatening arrhythmias rather than dietary modification.

Sodium polystyrene sulfonate removes potassium via gastrointestinal exchange, but onset is delayed over hours. It is useful for lowering potassium levels but not for immediate stabilization. It does not directly protect against acute cardiac effects of hyperkalemia.

Assessing skin turgor evaluates hydration status and is unrelated to bronchodilator effectiveness. Asthma management focuses on airway patency and ventilation. This intervention does not provide information about airflow improvement or bronchial smooth muscle relaxation.

Monitoring blood pressure and heart rate detects systemic side effects such as tachycardia from beta-agonists. However, it does not directly measure respiratory improvement. Cardiovascular changes do not indicate the degree of bronchodilation or airway responsiveness.

Capillary refill time assesses peripheral perfusion and circulatory status. It is not related to pulmonary function or airway patency. This measure does not reflect changes in respiratory status or effectiveness of bronchodilator therapy.

A dose of 500 mg represents a significant underdose for a 20 kg child. This error likely stems from using the wrong weight conversion factor or a calculation mistake. Inadequate dosing leads to subtherapeutic levels and clinical failure. It puts the patient at risk of unresolved pathology.

The value of 1200 mg is mathematically incorrect based on the provided weight and ratio. It does not correlate with standard conversion factors used in clinical practice. Administering this amount could lead to adverse drug reactions or toxicity. Precise calculation is mandatory for pediatric patient safety.

This incorrect answer results from multiplying 50 mg directly by the weight in pounds. This omission of the kilogram conversion is a frequent and dangerous medication error. Clinicians must always perform the weight conversion step first. Using lbs instead of kg leads to incorrect dosages.

Requesting additional pain medication indicates inadequate analgesia rather than impaired oxygenation. Pain may increase sympathetic activity but does not directly signify hypoxemia. This finding does not demonstrate compromised oxygen saturation or impaired respiratory gas exchange requiring oxygen therapy.

Mild discomfort at the surgical site is an expected postoperative finding related to tissue trauma. It does not indicate respiratory compromise or oxygenation issues. This symptom does not affect oxygenation status or necessitate immediate oxygen therapy intervention.

Slight increase in heart rate after walking is a normal physiologic response to activity. It reflects increased metabolic demand rather than hypoxia. This does not indicate impaired respiratory function or the need for supplemental oxygen.

While neurological depression can impair the gag reflex, it is a secondary complication. The primary physiological threat in severe electrolyte depletion is neuronal irritability. Aspiration precautions are important but do not address the immediate life-threatening cerebral swelling.

Skin integrity is a standard nursing concern for any bedridden patient but is not the priority here. The metabolic crisis of low sodium causes acute systemic instability that far outweighs the risk of pressure ulcers. Critical care focuses on stabilizing the solute concentration first.

Hyponatremia is often caused by hypervolemia or dilutional states rather than fluid volume deficit. Treating the patient for dehydration without knowing the underlying cause could worsen the sodium imbalance. The neurological symptoms of edema are more lethal than potential fluid fluctuations.

Administering a diuretic may increase water loss and worsen hypernatremia unless specifically indicated. It does not address the primary deficit of free water. This intervention can exacerbate fluid imbalance and further elevate sodium concentration.

Seizure precautions may be necessary in severe cases, but they are not the first priority. The underlying issue is dehydration and hyperosmolarity. Management must focus on correcting water deficit rather than only preventing complications.

Isotonic saline contains sodium and may worsen hypernatremia if used inappropriately. It is indicated in hypovolemia but not for correcting elevated sodium levels alone. This does not effectively reduce serum sodium concentration.

Monitoring serum calcium levels is important for ongoing management but does not address acute symptoms. It provides data rather than immediate treatment. This action does not correct neuromuscular instability or relieve current manifestations.

Providing calcium-rich dietary education supports long-term management of hypocalcemia. However, dietary intake does not act quickly enough in symptomatic cases. It is ineffective for immediate correction of acute deficiency and severe clinical manifestations.

Oral calcium supplements are useful for chronic management but have delayed absorption and onset. They are not appropriate for severe symptomatic hypocalcemia. This intervention does not rapidly reverse tetany or prevent acute complications.

A rate of 150 mL/hr would take 60 minutes to complete the infusion, which is double the requested time. This results in delayed therapy and subtherapeutic drug levels. The timing does not match the order. Patient safety is compromised.

Delivering the fluid at 200 mL/hr is an inaccurate rate based on the provided mathematical formula. This velocity would result in a prolonged infusion time of 45 minutes. It fails to meet the protocol. Consistency is vital.

A flow rate of 450 mL/hr is significantly too fast and could lead to rapid volume expansion. This increases the risk of iatrogenic complications like pulmonary edema or vascular irritation. The calculation error poses a threat.

Daily diuretic therapy reduces preload and relieves symptoms of congestion but does not prevent arrhythmias. Excessive preload reduction may worsen outflow obstruction. This intervention does not target the primary risk of sudden death in hypertrophic cardiomyopathy.

Beta-blockers improve diastolic filling and reduce heart rate, decreasing symptoms such as chest pain and dyspnea. However, they do not eliminate the risk of fatal arrhythmias. This therapy supports symptom control but not definitive arrhythmia prevention.

Lifestyle modifications such as reduced salt intake and controlled exercise improve overall cardiovascular health. However, they do not significantly reduce risk of lethal arrhythmias. These measures are supportive but ineffective for preventing sudden cardiac death.